Log in to search using one of your social media accounts:

 

Child ’s science experiment solves chronic disease mystery
“Chew this.” I was instructed. “But don’t swallow. Just tell me when IT happens.” IT? What was IT? I’d have to find out. My researcher’s son — who enlisted me in his science experiment — wasn’t telling. So I obliged and started chewing. It tasted just as I expected at first. Bland. Almost cardboard-like. And then the strangest thing occurred. After about a minute, a hint of sweetness tickled my tongue. I kept chewing. A few seconds later, it intensified… like I was sucking on candy. And a few seconds after that it felt like I had an entire spoonful of sugar...
Source: Al Sears, MD Natural Remedies - November 22, 2017 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Nutrition Weight Loss carbohydrates carbs disease sugar Syndrome Zero Source Type: news

The Zero Diet winning recipe …
We are all so excited over our cure for Syndrome Zero. All of my employees are behind this effort. And of course, we practice what we preach so we’re following the Zero Diet. It’s already having a dramatic effect on everybody’s health and we’re feeling better. We’re all doing it together as a team. My whole staff brought in a Zero Diet dish that we served for lunch. It was so hard to pick a winner that we picked three! Many of my employees have been doing this on their own at home. They’ve come up with some great recipes so we decided to have a cook-off. I asked every member of my st...
Source: Al Sears, MD Natural Remedies - November 22, 2017 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Nutrition Weight Loss carbohydrates carbs diet fat protien recipe Syndrome Zero Source Type: news

Normalize blood sugar with stem cell boosters
All the patients that I see in my clinic are special… But sometimes there’s a patient who really leaves a mark on you. I recently had a patient like that. He was living 3,000 miles away in Ireland and had seen one of my daily e-newsletters. Right after reading it, he made an appointment, booked a flight and came to my clinic in South Florida. I’ll call him K.O. About 10 years ago, K.O. was diagnosed with dangerously high blood sugar, type 2 diabetes and out-of-control blood pressure. He was 50 years old and taking 10 prescriptions a day. His kidneys were failing him and he was on the short list for a kid...
Source: Al Sears, MD Natural Remedies - November 22, 2017 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Anti-Aging Nutrition blood sugar carbs diabetes energy stem cells Syndrome Zero Source Type: news

Insulin Pill May Delay Type 1 Diabetes in Some
Title: Insulin Pill May Delay Type 1 Diabetes in SomeCategory: Health NewsCreated: 11/21/2017 12:00:00 AMLast Editorial Review: 11/22/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - November 22, 2017 Category: Endocrinology Source Type: news

Insulin Pill May Delay Type 1 Diabetes in Some
Researchers tested the effect of insulin pills on 560 children and adults whose relatives had type 1 diabetes. (Source: WebMD Health)
Source: WebMD Health - November 21, 2017 Category: Consumer Health News Source Type: news

Dexcom, Lilly ink deal to combine CGM into smart insulin delivery device
Dexcom (NSDQ:DXCM) said today that it inked a development deal with Eli Lilly (NYSE:LLY) to include its continuous glucose monitor in the insulin-maker’s connected delivery devices. The pair plans to start clinical trials by the end of this year, adding that they hope to position the combination of their technologies as a comprehensive solution for people with diabetes. Get the full story at our sister site, Drug Delivery Business News. The post Dexcom, Lilly ink deal to combine CGM into smart insulin delivery device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Patient Monitoring Pharmaceuticals Wall Street Beat Dexcom Eli Lilly & Co. Source Type: news

Insulin Pill May Delay Type 1 Diabetes in Some
Source: HealthDay Related MedlinePlus Pages: Diabetes Medicines, Diabetes Type 1 (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 21, 2017 Category: Consumer Health News Source Type: news

Oral Insulin Doesn't Stop Type 1 Diabetes in Those at Risk Oral Insulin Doesn't Stop Type 1 Diabetes in Those at Risk
The largest trial to date of oral insulin finds no protective effect in individuals with autoantibodies at high risk of developing type 1 diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Insulin Pill May Delay Type 1 Diabetes in Some
TUESDAY, Nov. 21, 2017 -- It's often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes. Researchers tested the effect of insulin pills on 560 children and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 21, 2017 Category: General Medicine Source Type: news

Diabetes: Immune system can regulate insulin
(University of Basel) Inflammation processes are responsible for the failure of insulin production in diabetes patients. The patients' own immune systems can contribute to treatment of this disease: researchers at the University of Basel and University Hospital Basel have found a feedback mechanism that could help maintain insulin production in overweight sufferers, as they report in the journal Immunity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news

Advice for CGM Trend Arrow Data to Tweak Insulin Doses in Diabetes Advice for CGM Trend Arrow Data to Tweak Insulin Doses in Diabetes
The latest Endocrine Society adult and pediatric guidelines provide a new method for using the Dexcom G5's trend arrows to help tweak insulin doses for diabetes patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Advice for CGM Trend Arrow Data to Adjust Insulin Doses in Diabetes Advice for CGM Trend Arrow Data to Adjust Insulin Doses in Diabetes
The latest Endocrine Society adult and pediatric guidelines provide a new method for using the Dexcom G5's trend arrows to help tweak insulin doses for diabetes patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Pre-diabetes discovery marks step towards precision medicine
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels. The finding, from a study undertaken in mice, could make earlier detection of pre-diabetes in humans much easier for doctors and allow for more personalised and effective treatments for patients in the future. (Source: World Pharma News)
Source: World Pharma News - November 20, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Health Ranger: How I beat type-2 diabetes using food, nutrition and exercise, avoiding a lifetime of insulin and toxic pharma drugs
(Natural News) Two decades ago, I was on the path to a lifetime of type-2 diabetes. Living on processed foods and lacking exercise, I suffered from hypoglycemia, high cholesterol and numerous other health problems. Like millions of people have now achieved, however, I turned my health around with simple but powerful changes in food, nutrition... (Source: NaturalNews.com)
Source: NaturalNews.com - November 17, 2017 Category: Consumer Health News Source Type: news

Chemical used in laundry detergent may help develop bioartificial pancreas
Chemicals used commonly in laundry detergents for their oxygen-producing properties may help advance type 1 diabetes research, by providing cells that produce insulin with the extra oxygen they need, a study inBiomaterials Science suggests. Phys.org (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 17, 2017 Category: Endocrinology Source Type: news

Like a baby: The vicious cycle of childhood obesity and snoring
(Beth Israel Deaconess Medical Center) In a new longitudinal observational study, scientists at Beth Israel Deaconess Medical Center (BIDMC) looked at the relationships among maternal snoring, childhood snoring and children's metabolic characteristics -- including body mass index (BMI) and insulin resistance, which reflects future risk for developing diabetes and cardiovascular disease -- in approximately 1,100 children followed from gestation through early adolescence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2017 Category: International Medicine & Public Health Source Type: news

Voluntis gets FDA clearance to add last two basal insulins to app
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a " digital companion " app for people with Type 2 diabetes. Insulia offers realtime basal insulin dose coaching, and the new clearance makes the app usable with two additional brands of insulin:  Basaglar and Tresiba. (Source: mobihealthnews)
Source: mobihealthnews - November 16, 2017 Category: Information Technology Source Type: news

Insulia wins FDA nod, CE Mark clearance to titrate Tresiba, Basaglar insulin
Voluntis said today that its digital management system for people with Type II diabetes, Insulia, won FDA clearance and CE Mark approval to integrate basal insulin brands Tresiba and Basaglar. The company’s software already works with Lantus, Toujeo and Levemir. The Insulia digital companion is composed of a patient mobile app and healthcare worker web portal. The app gives real-time basal insulin dosing recommendations and educational coaching messages based on blood glucose levels to patients with Type II diabetes. Get the full story at our sister site, Drug Delivery Business News. The post Insulia wins FDA no...
Source: Mass Device - November 16, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Voluntis Source Type: news

Over 50s can lower risk of dementia by exercising
Researchers from University College London found frail older people are 3.5 times more likely to be diagnosed with Alzheimer's disease or dementia one decade later, which may be due to insulin resistance. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

Eating more slowly may reduce obesity risk
According to a study, presented at the American Heart Association’s Scientific Sessions 2017, eating too quickly can cause blood sugar changes that predispose to insulin resistance and obesity.Independent (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 16, 2017 Category: Endocrinology Source Type: news

“Mistakes Were Made”
“When people take medicine at home, mistakes happen.”  That’s the start of a recent article on NPR’s web site, citing a new study that found that levels of medication errors are rising, and that most mistakes were preventable.  The researchers used information from U.S. poison control centers, and looked only at errors that happened outside of health care facilities.  Another study, cited in The New York Times, found that almost 85% of parents give children the wrong dose of liquid medicines, and more than 2 in 3 of those mistakes are overdoses.   What is behind these errors...
Source: Dragonfly - November 15, 2017 Category: Databases & Libraries Authors: Ann Glusker Tags: Health Literacy/Consumer Health Public Health Medication errors overdose Source Type: news

Amish Mutation Protects Against Diabetes and May Extend Life
Amish men and women who carried a genetic mutation appeared to be in better cardiovascular health and had longer telomeres, a barometer of longevity. (Source: NYT Health)
Source: NYT Health - November 15, 2017 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Diabetes Longevity Amish Research Blood Genetics and Heredity Obesity Insulin Chromosomes Source Type: news

Treating diabetes takes more than insulin: Senegal mobile phone project promoting public health
Since 2013, WHO has been working with the International Telecommunications Union (ITU) to help countries like Senegal introduce large-scale mDiabetes services using mobile phones. The joint initiative, Be He@lthy, Be Mobile, works to design, deploy and scale up prevention and management services for diabetes and a number of other noncommunicable diseases (NCDs). (Source: PHPartners.org)
Source: PHPartners.org - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Treating diabetes takes more than insulin: Senegal mobile phone project promoting public health
(Source: WHO Feature Stories)
Source: WHO Feature Stories - November 14, 2017 Category: International Medicine & Public Health Tags: diabetes [subject], diabetes mellitus, hyperglycaemia, glucose intolerance, diabetes [subject], diabetes mellitus, hyperglycaemia, glucose intolerance, ehealth [subject], medical informatics, African Region [region], Feature [doctype], Senegal [country] Source Type: news

Yerba mate's beneficial effects on cellular energy and lipid metabolism linked to weight
(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers have shown that use of the dietary supplement yerba mate over an extended period had significant effects on body weight and weight gain and was associated with lower levels of blood lipids and insulin in obese mice fed a high-fat diet. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
(Elsevier) Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Funding available! The National Network of Libraries of Medicine, Middle Atlantic Region, is accepting applications for health information outreach, health literacy initiatives, emergency preparedness partnerships and health sciences library projects. Applications will be due by COB on December 1. See a recent blog post from Executive Director, Kate Flewelling for details, or review our funding opportunities and start your application today! Rural Health Week begins on Monday, November 13! Wondering how you can participate?...
Source: NN/LM Middle Atlantic Region Blog - November 10, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Insulin dependence in type 2 diabetes reduced by bariatric surgery
According to a study, presented at Obesity Week 2017, bariatric surgery, in addition to producing weightloss, also successfully leads to more type 2 diabetes patients no longer requiring insulin.Healio  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news

Designing Connected Medical Devices: Overcoming Key RF Challenges
As medical devices become more sophisticated and are marketed as “wellness devices” instead of medical equipment, their form factor is also shrinking. That’s making Internet of Things (IoT)-based medical devices even more popular with patients who don’t want or need to be tethered to a hospital or healthcare facility for real-time monitoring. Analyst firm Berg Insight says in 2016, 7.1 million patients enrolled in some form of digital health program featuring “connected” medical devices as a core part of their care plan. Berg expects the number of remotely monitored patients will reach 5...
Source: MDDI - November 9, 2017 Category: Medical Devices Authors: Dermot O & #039;Shea Tags: Digital Health Source Type: news

What can gorillas teach us?
All the gorillas were dying… Over 50 years of trying to breed gorillas in zoos and nothing was working. It didn’t matter where they tried — San Diego, Cincinnati, St. Louis — not even the best zoos in the country could get these gorillas to reproduce. They were facing extinction. And everyone simply accepted that it was impossible to breed gorillas in zoos. That was until one caretaker took a closer look at what the gorillas were eating. For decades, zoos fed the gorillas what they called gorilla biscuits. But, on top of being unable to reproduce, the gorillas were developing diseases like heart di...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Natural Cures Nutrition carbs coconut oil diabetes gorillas heart disease high blood pressure insulin obesity Syndrome Zero triglycerides Source Type: news

Cardio: How many runners will collapse this weekend?
The New York City Marathon is this weekend. It’s the world’s biggest race with more than 50,000 people running 26 miles non-stop. I wonder how many lives will be claimed this year. I’m not exaggerating. It happens every time… Last year in London, 31-year-old Army captain David Seath collapsed three miles from the finish line. He died a few hours later. A couple years before that, two runners — ages 31 and 35 — died during a marathon in Raleigh, North Carolina. I was unfortunate enough to witness this pattern firsthand… About 30 years, I provided emergency care for marathon runner...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Fitness bread cardio cereal crackers exercise fat insulin New York City Marathon Weight Loss Source Type: news

Diabetes is not genetic
She was a beautiful woman. A patient who was easy for me to relate to. When she started to weep, I understood. I’ve heard stories like hers hundreds of times since the beginning of my career, back in Lake Worth in 1992. Let me tell you why I think this is important for you. She said, “My doctor told me I have diabetes, and it’s incurable.” So I told her, you’re not broken. There is no gene for type 2 diabetes. The things we’ve been telling people about diabetes being genetic is just dead wrong. Research has shown that genetic predispositions for most chronic diseases explain very little ...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures Nutrition Chronic diseases diabetes diet Glycemic glycemic index GMO grains high Glycemic foods low-glycemic food Syndrome Zero Source Type: news

Urgent news about syndrome zero
I have urgent news. I consider this to be the biggest health crisis of all time. As a matter of fact, it’s a rapidly growing pandemic spreading around the world. When we look at the rate of new incidences, it’s only a matter of time before every man, woman and child on the planet will be affected. But what’s truly alarming is that it’s at the very root of every chronic disease plaguing our modern world. Cancer Heart disease Diabetes Obesity Alzheimer’s I named this emerging new threat Syndrome Zero. And while mainstream medicine has yet to connect the dots like I have, evidence that supports...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Natural Cures Alzheimer's Cancer Chronic diseases diabetes heart disease obesity Syndrome Zero Source Type: news

Join my unique protocol to eliminate Syndrome Zero
Today I want to talk to you about how to beat the most urgent public health threat of our time — a condition I call Syndrome Zero. This condition is at the root of almost every chronic disease we face today — including obesity, heart disease, cancer, Alzheimer’s, arthritis, high blood pressure, metabolic syndrome, diabetes and even hip fractures. It already afflicts billions of people on the planet — and within a matter of decades, it will see nearly every man, woman and child in America suffer from at least one chronic disease. The good news is that this plague is stoppable. But here’s the pr...
Source: Al Sears, MD Natural Remedies - November 7, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Alzheimer's arthritis Cancer diabetes heart disease high blood pressure hip fractures metabolic syndrome obesity Syndrome Zero Source Type: news

Bigfoot compares trial data with modeling results for automated insulin delivery system
Bigfoot Biomedical touted data last week at this year’s Diabetes Technology Meeting showing that results from a feasibility study evaluating the company’s automated insulin delivery system closely matched data gleaned from prospective modeling. The company said it conducted extensive modeling to refine the technology’s algorithms prior to the start of its trial in 2016, Bigfoot said. Data collected from simulations closely predicted how Bigfoot’s automated insulin delivery system would perform when tested in a group of diverse patients. Get the full story at our sister site, Drug Delivery Busin...
Source: Mass Device - November 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diabetes Drug-Device Combinations Pharmaceuticals Research & Development Bigfoot Biomedical Source Type: news

Q & amp;A: How to Prepare for an AI-Driven Future
For years the role of robotics and artificial intelligence within the realm of medtech has been hyped as the future of innovation and device development. Now that technological advances are beginning to catch up to our imagination, how will advanced robotic and AI technologies begin to reshape the medtech landscape?  Srihari Yamanoor With advances in machine learning and robotic design, artificial intelligence is poised to have a dramatic impact on the medical device field. With innovative opportunities on both the diagnostic and therapeutic sides of medicine, AI technologies could be the key that unlocks...
Source: MDDI - November 7, 2017 Category: Medical Devices Authors: Kristopher Sturgis Tags: BIOMEDevice San Jose Assembly and Automation Digital Health Source Type: news

Stress is bad for your health. Today's political uncertainty makes it worse
Americans are exposed to one of the most damaging sources of stress: uncertainty. The assault on our fundamental sense of security can make us sickOutclassed: The Secret Life of Inequality is our new column about class.Read all articles hereDavid Dobbs ’ 13-year-old daughter has type 1 diabetes. Since 2015, the 59-year-old freelance writer and author has relied on Obamacare, officially known as the Affordable Care Act (ACA), to help pay for his daughter’s insulin, blood testing supplies and other medical needs. But as the endless series of cli ffhangers over the fate of the ACA continues, Dobbs says he’s ...
Source: Guardian Unlimited Science - November 7, 2017 Category: Science Authors: Maia Szalavitz Tags: Inequality Health Science Society US healthcare Source Type: news

Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs
(University of Alabama at Birmingham) Researchers have found a vital role for miR-204 in beta cells -- regulating the cell surface receptor that is the target of many of the newer type 2 diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta. This drug target is the glucagon-like peptide 1 receptor, or GLP1R. Activation of GLP1R with these drugs helps the beta cell produce and secrete more insulin. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2017 Category: International Medicine & Public Health Source Type: news

Mayo Clinic Minute: Is Alzheimer's Type 3 diabetes?
This study has furthered our understanding of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 7, 2017 Category: Databases & Libraries Source Type: news

A Quest: Insulin-Releasing Implant For Type-1 Diabetes
(Source: NPR Health and Science)
Source: NPR Health and Science - November 6, 2017 Category: Consumer Health News Authors: Joe Palca Source Type: news

Sustained Diabetes Prevention Achieved With Lifestyle Changes Sustained Diabetes Prevention Achieved With Lifestyle Changes
In individuals with prediabetes, lifestyle changes and weight loss or insulin-sensitizing medications slowed the progression to type 2 diabetes, in a large meta-analysis. Weight loss appears key.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Bariatric Surgery: Many Can Come Off Insulin Long Term Bariatric Surgery: Many Can Come Off Insulin Long Term
A retrospective follow-up finds 44% of obese patients with insulin-treated type 2 diabetes are able to stop insulin for 5 or more years after bariatric surgery.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

FDA ’s role in medical device cybersecurity
By: Suzanne Schwartz, M.D., M.B.A. Virtually every aspect of our lives – including our health – has gone digital. Medical devices from insulin pumps to implantable cardiac pacemakers are becoming more interconnected and, like computers and the networks they operate in can be vulnerable to security breaches. A computer virus or hack resulting in the loss of or unauthorized use of data is one thing. A breach that potentially impacts the safety and effectiveness of a medical device can threaten the health and safety of an individual or patients using the device. Global cyber-attacks in 2017, including WannaCr...
Source: Mass Device - November 6, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog FDA Voice Source Type: news

Stem cells pave the way for new treatment of diabetes
(University of Copenhagen The Faculty of Health and Medical Sciences) A new stem cell study conducted at the University of Copenhagen shows how we may increase the vital production of insulin in patients suffering from diabetes. The discovery helps to more efficiently at less cost make insulin-producing beta cells from human stem cells. Therefore, the research paves the way for more effective treatment of diabetes. The method may also prove significant to the treatment of a series of other diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 6, 2017 Category: International Medicine & Public Health Source Type: news

Valeritas & #226; �(TM) V-Go & #194; & #174; Wearable Insulin Delivery Device, Combined ...
BRIDGEWATER, N.J., Nov. 03, 2017 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies, announced today positive findings from a analysis conducted combining its V-Go® Wearable Basal plus Bolus Insulin Delivery Device with a weekly physician-driven, simplified prandial-focused insulin titration algorithm. Achievement of glycemic targets...This story is related to the following:Medical Devices | (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - November 4, 2017 Category: Medical Devices Source Type: news

Valeritas touts study of V-Go insulin delivery device paired with insulin titration algorithm
Valeritas (NSDQ:VLRX) touted positive findings today from an analysis of its V-Go wearable insulin delivery system with a weekly physician-driven insulin titration algorithm. Two-thirds of patients met their glycemic targets, the company said, and patient-reported hypoglycemia dropped by the end of the study. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas touts study of V-Go insulin delivery device paired with insulin titration algorithm appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Living with NASH: An Unexpected Diagnosis
As our waistlines thicken and our activity levels decrease, another chronic illness threatens to disturb our comfortable lifestyles. And, because it ’s relatively unknown, diagnosis comes as a shock to patients, who usually associate liver disease with heavy consumption of alcohol.Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD), where fat accumulates in the liver. It is most commonly associated with obesity, insulin resistance, metabolic syndrome and/or genetic polymorphisms, and is aggravated by inflammation and fibrosis.  First identified in the 1980s, its ...
Source: EyeForPharma - November 3, 2017 Category: Pharmaceuticals Authors: Mariel Metcalfe Source Type: news

Study refutes using anti-malaria drug to treat diabetes
(University of California - Davis) A drug used to treat malaria does not, after all, create new insulin-producing cells, according to a new paper from researchers at UC Davis. The work, published in Cell Metabolism Nov. 3, refutes a study published in Cell in January. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2017 Category: International Medicine & Public Health Source Type: news

BD ’s Insulin Patch Pump Is Coming . . . a Bit Later Than Expected
BD last year announced its intention to dive into the emerging market for insulin patch pumps for patients with type 2 diabetes, with an expected product launch sometime in the company’s 2018 fiscal year. But in the company’s fourth-quarter 2017 earnings call November 2, management revised that timeline. “. . . [W]e had said before we were expecting to launch that at the very end of FY 2018,” said BD president Thomas Polen, according to a transcript from Seeking Alpha. “Based on some learnings actually from other product launches, we did add in an additional patient clinical trial there, and s...
Source: MDDI - November 3, 2017 Category: Medical Devices Authors: Jamie Hartford Tags: Medical Device Business Adhesives Source Type: news